CIK 0001549595
- Large accelerated filer
Nurix Therapeutics, Inc.
Sign in to watch- Ticker
- NRIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Nov 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 270838048
- Phone
- +1 415-660-5320
- Business address
- 1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
- Former names
- Nurix, Inc.
- 4 Open-market sale Chief Scientific Officer sold 4,308 shares at $12.01 ($51,743)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Chief Financial Officer sold 6,198 shares at $11.33 ($70,243)
- 4 Open-market sale Chief Scientific Officer sold 3,377 shares at $11.50 ($38,841)
- 4 Open-market sale Chief Legal Officer sold 2,894 shares at $11.50 ($33,286)
- 4 Open-market sale Chief Financial Officer sold 2,438 shares at $11.50 ($28,041)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Chief Financial Officer sold 5,825 shares at an average $14.49 ($84,388)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 4 of 14 · 274 filings